Product Information
NORELGESTROM-EE 150-35 MCG/DAY is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $33.2895 per EA under NDC 70710119003. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Sep 14, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
35; 150 ug/mg; ug/mg
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710119003
Classification
Generic
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
ETHINYL ESTRADIOL; NORELGESTROMINApproval Type
Generic (ANDA)
FDA Application
ANDA214594FDA Approved
9/14/2023
TE Code
AB
On Market Since
11/21/2023
Price Statistics
The NADAC for NORELGESTROM-EE 150-35 MCG/DAY has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 36.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $33.2895 per EA |
|---|---|
| All-time high | $38.0867 (Dec 11, 2024) |
| All-time low | $24.0790 (Jul 17, 2024) |
| 52-week high | $36.7300 |
| 52-week low | $33.2895 |
| Median price | $36.4771 |
| Average price | $35.1905 |
| Largest weekly change | +51.2% (Jun 19, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
norelgestromin and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORELGESTROM-EE 150-35 MCG/DAY?
The current National Average Drug Acquisition Cost (NADAC) for NORELGESTROM-EE 150-35 MCG/DAY, manufactured by Zydus Pharmaceuticals (USA) Inc., is $33.2895 per EA (NDC 70710119003), effective Sep 30, 2026.
How has the price of NORELGESTROM-EE 150-35 MCG/DAY changed over time?
Over the history we have for it, the NADAC for NORELGESTROM-EE 150-35 MCG/DAY has risen 36.4%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for NORELGESTROM-EE 150-35 MCG/DAY?
Since Apr 17, 2024, the NADAC for NORELGESTROM-EE 150-35 MCG/DAY has ranged from a low of $24.0790 (Jul 17, 2024) to a high of $38.0867 (Dec 11, 2024), with a median of $36.4771 per EA.
Are there cheaper alternatives to NORELGESTROM-EE 150-35 MCG/DAY?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NORELGESTROM-EE 150-35 MCG/DAY in a comparable dosage form, but none are currently priced below it.
Who manufactures NORELGESTROM-EE 150-35 MCG/DAY?
NORELGESTROM-EE 150-35 MCG/DAY (NDC 70710119003) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.